On May 20, 2024, Accelerate Diagnostics, Inc. closed the transaction. The company has now issued 2,716,763 units at a price of $1.73 per unit for the gross proceeds of $4,699,999.99 in the transaction. The company has issued 1,156,069 Units at a price of $1.73 per unit for gross proceeds of $2,700,000.62 in its second and final tranche closing.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.14 USD | -2.56% |
|
0.00% | -70.66% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-70.66% | 27.63M | |
-0.27% | 205B | |
+3.29% | 178B | |
+31.07% | 158B | |
+31.98% | 112B | |
+1.79% | 64.58B | |
+22.38% | 55.34B | |
-3.27% | 46.64B | |
-10.43% | 36.78B | |
-1.03% | 34.85B |
- Stock Market
- Equities
- AXDX Stock
- News Accelerate Diagnostics, Inc.
- Accelerate Diagnostics, Inc. announced that it has received $4.7 million in funding from Jack W. Schuler Living Trust